Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06042062Not ApplicableUnknown

Clinical Evaluation of Infection Control to Knee Periprosthetic Joint Infection (PJI) -United Cellbrick Knee Spacer

Role: collaborator

NCT04501185Recruiting

Comparison of Clinical Results of Two Cementless Femoral Stem

Role: collaborator

NCT03060057Active Not Recruiting

Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System - "U-Propel Study"

Role: lead

NCT02761499Unknown

Post Approval Study of the Commercially Available U-Motion II+ Acetabular System and UTF Reduced Stem

Role: lead

All 4 trials loaded